This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Prabu-Jeyabalan, M. Articles by Schiffer, C. A. Search for Related Content PubMed PubMed Citation Articles by Prabu-Jeyabalan, M. Articles by Schiffer, C. A.

 Previous Article  |  Next Article 

Journal of Virology, April 2006, p. 3607-3616, Vol. 80, No. 7
0022-538X/06/$08.00+0     doi:10.1128/JVI.80.7.3607-3616.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Mechanism of Substrate Recognition by Drug-Resistant Human Immunodeficiency Virus Type 1 Protease Variants Revealed by a Novel Structural Intermediate

Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, 364 Plantation Street, Worcester, Massachusetts 01605

Received 22 November 2005/ Accepted 17 January 2006

Human immunodeficiency virus type 1 (HIV-1) protease processes and cleaves the Gag and Gag-Pol polyproteins, allowing viral maturation, and therefore is an important target for antiviral therapy. Ligand binding occurs when the flaps open, allowing access to the active site. This flexibility in flap geometry makes trapping and crystallizing structural intermediates in substrate binding challenging. In this study, we report two crystal structures of two HIV-1 protease variants bound with their corresponding nucleocapsid-p1 variant. One of the flaps in each of these structures exhibits an unusual "intermediate" conformation. Analysis of the flap-intermediate and flap-closed crystal structures reveals that the intermonomer flap movements may be asynchronous and that the flap which wraps over the P3 to P1 (P3-P1) residues of the substrate might close first. This is consistent with our hypothesis that the P3-P1 region is crucial for substrate recognition. The intermediate conformation is conserved in both the wild-type and drug-resistant variants. The structural differences between the variants are evident only when the flaps are closed. Thus, a plausible structural model for the adaptability of HIV-1 protease to recognize substrates in the presence of drug-resistant mutations has been proposed.

This article has been cited by other articles:

• Bandaranayake, R. M., Prabu-Jeyabalan, M., Kakizawa, J., Sugiura, W., Schiffer, C. A. (2008). Structural Analysis of Human Immunodeficiency Virus Type 1 CRF01_AE Protease in Complex with the Substrate p1-p6. J. Virol. 82: 6762-6766 [Abstract] [Full Text]  
• Koh, Y., Matsumi, S., Das, D., Amano, M., Davis, D. A., Li, J., Leschenko, S., Baldridge, A., Shioda, T., Yarchoan, R., Ghosh, A. K., Mitsuya, H. (2007). Potent Inhibition of HIV-1 Replication by Novel Non-peptidyl Small Molecule Inhibitors of Protease Dimerization. J. Biol. Chem. 282: 28709-28720 [Abstract] [Full Text]